MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/07/2006
Outstanding shares:  49,043,246
Average volume:  878,185
Market cap:   $153,995,792
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    58468P206
ISIN:        US58468P2065
Sedol:      B1L2QM5
Valuation   (See tab for details)
PE ratio:   -19.07
PB ratio:   1.77
PS ratio:   26.46
Return on equity:   -12.76%
Net income %:   -189.63%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy